Certified by Founder Lodge
Pfizer
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $125,000,000
30 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Breakthroughs That Change Patients' Lives: Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend
| Company | Date | Round | Raised |
|---|---|---|---|
 ReCode Therapeutics |
September, 20 ,2023 | Series B | $50,000,000 |
 Nimbus Therapeutics |
September, 13 ,2022 | Unknown | $125,000,000 |
 RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
 VitaDAO |
February, 15 ,2023 | Unknown | $4,100,000 |
 Curve Therapeutics |
February, 28 ,2024 | Series A | $51,183,495 |
 Mediar Therapeutics |
March, 15 ,2023 | Unknown | $105,000,000 |
 Mission Therapeutics |
March, 15 ,2024 | Unknown | $32,101,650 |
 Flare Therapeutics |
March, 23 ,2023 | Series B | $123,000,000 |
 Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
 Vedanta Biosciences, Inc. |
April, 26 ,2023 | Unknown | $106,500,000 |
 Grey Wolf Therapeutics |
May, 23 ,2024 | Series B | $50,000,000 |
 Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
 Enara Bio |
October, 04 ,2024 | Series B | $32,500,000 |
 Crossbow Therapeutics, Inc |
July, 12 ,2023 | Series A | $80,000,000 |
 TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
 CellCentric |
July, 24 ,2023 | Unknown | $25,000,000 |
 Normunity |
January, 14 ,2025 | Series B | $75,000,000 |
| ReCode Therapeutics |
September, 20 ,2023 | Series B | $50,000,000 |
 TRIMTECH Therapeutics Limited |
March, 07 ,2025 | Seed | Undisclosed Amount |
| RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
 TRIANA Biomedicines |
December, 04 ,2025 | Series B | $120,000,000 |
| Curve Therapeutics |
February, 28 ,2024 | Series A | $51,183,495 |
| Mission Therapeutics |
March, 15 ,2024 | Unknown | $32,101,650 |
| Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
| Grey Wolf Therapeutics |
May, 23 ,2024 | Series B | $50,000,000 |
| Enara Bio |
October, 04 ,2024 | Series B | $32,500,000 |
| TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
| Normunity |
January, 14 ,2025 | Series B | $75,000,000 |
| TRIMTECH Therapeutics Limited |
March, 07 ,2025 | Seed | Undisclosed Amount |
| TRIANA Biomedicines |
December, 04 ,2025 | Series B | $120,000,000 |
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Ridley | $6,400,000 | (Dec 4, 2025)
Autolane | $7,400,000 | (Dec 4, 2025)
Juniper Biosciences | $40,000,000 | (Dec 4, 2025)
PineAI | $25,000,000 | (Dec 4, 2025)
